DAWN GOODPASTER: Open Payments
NPI 1467474601 · INVERNESS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 20 payments from 9 companies in 2025. Trend: 2023 $80 · 2024 $109 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $281 |
| Amgen Inc. | 5 | $170 |
| Stryker Corporation | 1 | $100 |
| ABBVIE INC. | 3 | $76 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Lilly USA, LLC | 1 | $32 |
| Lundbeck LLC | 1 | $26 |
| PFIZER INC. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $8 |
Products named: BREZTRI, REPATHA, FLOWTRIEVER CATHETER, S, TRELEGY ELLIPTA, VRAYLAR, OTEZLA, JARDIANCE, REXULTI.
Industry payments across FL — which companies pay providers there.
